Felix Pharmaceuticals Pvt. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Felix Pharmaceuticals Pvt. Ltd. - overview
Established
2014
Location
Dublin, -, Ireland
Primary Industry
Healthcare Specialists
About
Felix Pharmaceuticals Pvt. Ltd. , based in Ireland, specializes in developing and manufacturing high-quality veterinary pharmaceutical products tailored for companion animals, enhancing their health and well-being. Founded in 2014 in Dublin, Ireland, Felix Pharmaceuticals Pvt.
Ltd. focuses on veterinary pharmaceuticals. The company has completed one deal, with the most recent being a BUYOUT in June 2025 when Advent International acquired a minority stake for USD 175 mn. The total amount raised to date is USD 175 mn.
Felixvet specializes in developing, manufacturing, and marketing high-quality veterinary pharmaceutical products for companion animals. Their product range includes conventional generics, value-added generics, and complex generics that are bio-equivalent to existing medications. The portfolio consists of over 65 items in various stages of development or approval with the US FDA, including 10 products available in the United States, catering to veterinarians, pet owners, and animal healthcare providers across top ten global veterinary markets. Felixvet generates revenue through direct sales and licensing agreements within the veterinary pharmaceutical industry.
The company engages in B2B transactions with veterinary clinics and animal hospitals, employing established distribution networks. Their transactions primarily involve the sale of individual pharmaceutical products, with competitive pricing structures designed to be affordable for veterinary practices and pet owners. Key offerings include flagship generic medications that address common pet health conditions, contributing positively to the wellness of companion animals. Looking forward, Felix Pharmaceuticals Pvt.
Ltd. aims to expand its product portfolio by launching new products designed for the veterinary market. Recent funding from the acquisition by Advent International will support these initiatives, enhancing their commercial capabilities. The company is also targeting expansion into new geographic regions and markets, although specific locations and timelines are yet to be detailed.
The recent acquisition allows for strategic growth within the industry, strengthening their position in the veterinary pharmaceutical landscape.
Primary Industry
Healthcare Specialists
Sub Industries
Healthcare Specialists
Website
www.felixvet.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Felix Pharmaceuticals Pvt. Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Announced | Felix Pharmaceuticals Pvt. Ltd. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.